Patrice D. Cani mostly deals with Gut flora, Internal medicine, Endocrinology, Insulin resistance and Prebiotic. Patrice D. Cani interconnects Inflammation, Obesity and Type 2 diabetes in the investigation of issues within Gut flora. His biological study spans a wide range of topics, including Lipopolysaccharide and Endocannabinoid system.
His Internal medicine research incorporates themes from Gastroenterology and Proglucagon. His study looks at the intersection of Insulin resistance and topics like Biochemistry with Systems biology. His research integrates issues of Probiotic, Bifidobacterium, Intestinal absorption and Microbiology in his study of Prebiotic.
Patrice D. Cani mainly investigates Gut flora, Internal medicine, Endocrinology, Immunology and Obesity. The Gut flora study combines topics in areas such as Inflammation, Prebiotic and Microbiology. His research in Inflammation intersects with topics in Endocannabinoid system and Pharmacology.
The study of Internal medicine is intertwined with the study of Type 2 diabetes in a number of ways. Diabetes mellitus, Glucose homeostasis, Carbohydrate metabolism, Insulin and Glucagon-like peptide-1 are the subjects of his Endocrinology studies. His Obesity study integrates concerns from other disciplines, such as Physiology and Bioinformatics.
His primary areas of investigation include Gut flora, Internal medicine, Endocrinology, Obesity and Prebiotic. His Gut flora research incorporates elements of Microbiome, Steatosis, Bifidobacterium, Inflammation and Microbiology. His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Conjugated linoleic acid and Alcohol use disorder.
His Endocrinology research integrates issues from Cachexia and Akkermansia muciniphila. In general Obesity study, his work on Overweight often relates to the realm of Context, thereby connecting several areas of interest. His biological study spans a wide range of topics, including Feces, Akkermansia, Inulin, Placebo and Pharmacology.
His primary scientific interests are in Gut flora, Internal medicine, Endocrinology, Akkermansia muciniphila and Immune system. The Gut flora study combines topics in areas such as Microbiome, Bioinformatics, Obesity, Prebiotic and Mediterranean diet. His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Type 2 diabetes and Neuroscience.
His research is interdisciplinary, bridging the disciplines of Phenotype and Endocrinology. His research in Akkermansia muciniphila intersects with topics in Lipid metabolism, Bone marrow and Mesenteric lymph nodes. His work investigates the relationship between Lipid metabolism and topics such as Diet-induced obese that intersect with problems in Adipose tissue.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani;Jacques Amar;Miguel Angel Iglesias;Marjorie Poggi.
Diabetes (2007)
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D. Cani;Rodrigo Bibiloni;Claude Knauf;Aurélie Waget.
Diabetes (2008)
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Amandine Everard;Clara Belzer;Lucie Geurts;Janneke P. Ouwerkerk.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
Patrice D. Cani;S. Possemiers;T. Van de Wiele;Yves Guiot.
Gut (2009)
Prebiotic effects: metabolic and health benefits.
Marcel Roberfroid;Glenn R. Gibson;Lesley Hoyles;Anne L. McCartney.
British Journal of Nutrition (2010)
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.
Patrice D. Cani;Audrey M. Neyrinck;F Fava;Claude Knauf.
Diabetologia (2007)
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson;Robert Hutkins;Mary Ellen Sanders;Susan L. Prescott.
Nature Reviews Gastroenterology & Hepatology (2017)
The role of the gut microbiota in energy metabolism and metabolic disease.
Patrice D. Cani;Nathalie M. Delzenne.
Current Pharmaceutical Design (2009)
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
Maria Carlota Dao;Amandine Everard;Judith Aron-Wisnewsky;Nataliya Sokolovska.
Gut (2016)
Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice
Amandine Everard;Vladimir Lazarevic;Muriel Derrien;Myriam Girard.
Diabetes (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Catholique de Louvain
University of Helsinki
Inserm : Institut national de la santé et de la recherche médicale
University of Gothenburg
Paul Sabatier University
Cliniques Universitaires Saint-Luc
Université Catholique de Louvain
Geneva College
Geneva College
University of Reading
University of Melbourne
University of Cincinnati
University of Zurich
University of Hannover
Centro Internacional de Agricultura Tropical
Universidade de Vigo
University of Lorraine
University of Tennessee at Knoxville
Showa University
The University of Texas Health Science Center at Houston
Brown University
Chinese Academy of Sciences
University of Nebraska–Lincoln
Ocean University of China
Arizona State University
Tsinghua University